These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20683665)

  • 1. In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotide.
    Logan AE; Wilson TR; Fenning C; Cummins R; Kay E; Johnston PG; Longley DB
    Apoptosis; 2010 Dec; 15(12):1435-43. PubMed ID: 20683665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing.
    Wilson TR; Redmond KM; McLaughlin KM; Crawford N; Gately K; O'Byrne K; Le-Clorrenec C; Holohan C; Fennell DA; Johnston PG; Longley DB
    Cell Death Differ; 2009 Oct; 16(10):1352-61. PubMed ID: 19543235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of c-FLIP and survivin down-regulation in flexible heteroarotinoid-induced apoptosis and enhancement of TRAIL-initiated apoptosis in lung cancer cells.
    Lin Y; Liu X; Yue P; Benbrook DM; Berlin KD; Khuri FR; Sun SY
    Mol Cancer Ther; 2008 Nov; 7(11):3556-65. PubMed ID: 19001438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
    Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung Cancer.
    McLaughlin KA; Nemeth Z; Bradley CA; Humphreys L; Stasik I; Fenning C; Majkut J; Higgins C; Crawford N; Holohan C; Johnston PG; Harrison T; Hanna GG; Butterworth KT; Prise KM; Longley DB
    Mol Cancer Ther; 2016 Oct; 15(10):2432-2441. PubMed ID: 27474150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling.
    Kaminskyy VO; Surova OV; Piskunova T; Zborovskaya IB; Tchevkina EM; Andera L; Zhivotovsky B
    Cell Death Dis; 2013 Mar; 4(3):e522. PubMed ID: 23470529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Cancer Res; 2006 Dec; 66(23):11115-9. PubMed ID: 17145853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-FLIP: a key regulator of colorectal cancer cell death.
    Wilson TR; McLaughlin KM; McEwan M; Sakai H; Rogers KM; Redmond KM; Johnston PG; Longley DB
    Cancer Res; 2007 Jun; 67(12):5754-62. PubMed ID: 17575142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway.
    Elrod HA; Lin YD; Yue P; Wang X; Lonial S; Khuri FR; Sun SY
    Mol Cancer Ther; 2007 Jul; 6(7):2029-38. PubMed ID: 17604333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents.
    Klingbeil O; Lesche R; Gelato KA; Haendler B; Lejeune P
    Cell Death Dis; 2016 Sep; 7(9):e2365. PubMed ID: 27607580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer.
    Riley JS; Hutchinson R; McArt DG; Crawford N; Holohan C; Paul I; Van Schaeybroeck S; Salto-Tellez M; Johnston PG; Fennell DA; Gately K; O'Byrne K; Cummins R; Kay E; Hamilton P; Stasik I; Longley DB
    Cell Death Dis; 2013 Dec; 4(12):e951. PubMed ID: 24309938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
    Fan S; Li Y; Yue P; Khuri FR; Sun SY
    Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pseudo-caspase FLIP(L) regulates cell fate following p53 activation.
    Lees A; McIntyre AJ; Crawford NT; Falcone F; McCann C; Holohan C; Quinn GP; Roberts JZ; Sessler T; Gallagher PF; Gregg GMA; McAllister K; McLaughlin KM; Allen WL; Egan LJ; Ryan AE; Labonte-Wilson MJ; Dunne PD; Wappett M; Coyle VM; Johnston PG; Kerr EM; Longley DB; McDade SS
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17808-17819. PubMed ID: 32661168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cordycepin induces autophagy-mediated c-FLIPL degradation and leads to apoptosis in human non-small cell lung cancer cells.
    Yu X; Ling J; Liu X; Guo S; Lin Y; Liu X; Su L
    Oncotarget; 2017 Jan; 8(4):6691-6699. PubMed ID: 28035061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.
    Zou W; Chen S; Liu X; Yue P; Sporn MB; Khuri FR; Sun SY
    Cancer Biol Ther; 2007 Oct; 6(10):1614-20. PubMed ID: 18253090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy.
    McCourt C; Maxwell P; Mazzucchelli R; Montironi R; Scarpelli M; Salto-Tellez M; O'Sullivan JM; Longley DB; Waugh DJ
    Clin Cancer Res; 2012 Jul; 18(14):3822-33. PubMed ID: 22623731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells.
    Wang X; Chen W; Zeng W; Bai L; Tesfaigzi Y; Belinsky SA; Lin Y
    Mol Cancer Ther; 2008 May; 7(5):1156-63. PubMed ID: 18483303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells.
    Wilson C; Wilson T; Johnston PG; Longley DB; Waugh DJ
    Mol Cancer Ther; 2008 Sep; 7(9):2649-61. PubMed ID: 18790747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8.
    Chacko AD; Liberante F; Paul I; Longley DB; Fennell DA
    BMC Cancer; 2010 Jul; 10():380. PubMed ID: 20646307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.